Behavioral cough therapy should be used as early intervention, said Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.
Behavioral cough therapy should be used as early intervention, said Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.
Transcript
What is the benefit of using behavioral cough therapy in patients with chronic cough and using it early?
One of my passions is increasing awareness of this therapy, that it should be considered early. So most of these patients go through all kinds of tests and see several doctors before they come to see us. But my strong belief is that physicians should rule out anything serious, and there's ways to do that: chest X-ray and different tests. But once the serious things have been ruled out, if they have a dry cough, I think that they should try this therapy much, much sooner because it does improve their situation within a few weeks. And it takes longer than that, usually, to get in to see a specialist. And then the other thing is that, the data on patients that come to speech therapy are all patients that nothing else has really worked well for them, so they're already tricky patients. The data that we have shows that it is helpful. [It] doesn't mean the cough completely goes away, but it's helpful for 70 to 88% of patients, so the success rate is really quite high. In my own research, I did a huge survey study and over 50% said that they were quite satisfied that their cough was drastically improved after the therapy. So it's underutilized in my opinion, and it shouldn't be considered as a last resort, it should be considered more early intervention.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More